Login / Signup

Transdermal oestradiol as a method of androgen suppression for prostate cancer within the STAMPEDE trial platform.

Duncan C GilbertTrinh DuongMatthew Robert SydesAnna BaraNoel ClarkePaul AbelNicholas D JamesRuth LangleyMax Parmarnull null
Published in: BJU international (2018)
Keyphrases
  • prostate cancer
  • radical prostatectomy
  • phase iii
  • study protocol
  • phase ii
  • clinical trial
  • high throughput
  • randomized controlled trial
  • open label